Myocarditis natural history, complications and prognosis

Revision as of 18:05, 18 August 2011 by Varun Kumar (talk | contribs)
Jump to navigation Jump to search

Myocarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Adrenergic Myocarditis
Giant Cell Myocarditis

Causes

Differentiating Myocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myocarditis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Myocarditis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myocarditis natural history, complications and prognosis

CDC on Myocarditis natural history, complications and prognosis

Myocarditis natural history, complications and prognosis in the news

Blogs on Myocarditis natural history, complications and prognosis

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Myocarditis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S.

Natural history

Myocarditis with myocardial infarction like ECG changes are usually self limiting with no overt sequelae[1]. Patients with ECG changes suggestive of bundle branch block, old infarct or high degree AV block are associated with poor long term prognosis and may progress to develop cardiac failure. Viral myocarditis are usually benign and majority of cases of Coxsackie B virus infection are subclinical.

Patients presenting with mild ventricular dysfunction secondary to viral myocarditis typically improve within weeks to months and rarely, may progress to severe ventricular dysfunction and may lead to arrhythmias or even death[2]. Though only a small fraction of patients with lymphocytic myocarditis develop ventricular arrhythmias, idiopathic ventricular tachycardia is seen in upto 33% of these patients[3].

Complications

As mentioned above, myocarditis may present with ventricular dysfunction and may progress to cardiac failure due to presence of scar tissue. This can further lead to development of pulmonary edema, arrhythmias or cardiogenic shock.

Other complications include recurrent myositis, cardiac conduction abnormalities and may even lead to sudden death[3].

Prognosis

Endomyocardial biopsy which is the primary diagnostic tool is used usually in patients presenting with advanced heart failure or arrhythmias and thus long term prognosis in mild cases is not known. Prognosis in myocarditis varies with the cause and the severity of the disease.

Development of syncope, bundle branch block, ejection fraction <40% and pulmonary hypertension are known to be poor predictors of myocarditis and can lead to subsequent death or transplantation[4].

In a series, among 15 patients who met the criteria for fulminant myocarditis, 14(93%) patients survived for 11 years without the need for heart transplant. This suggests that patients with fulminant myocarditis have a good long term prognosis if they survive the acute phase of the disease[5]. In the same series, 132 patients met the criteria for acute myocarditis and 60(45%) of these patients were alive at the end of 11 years without having received a transplant.

References

  1. Dec GW, Waldman H, Southern J, Fallon JT, Hutter AM, Palacios I (1992). "Viral myocarditis mimicking acute myocardial infarction". J Am Coll Cardiol. 20 (1): 85–9. PMID 1607543.
  2. Wentworth P, Jentz LA, Croal AE (1979). "Analysis of sudden unexpected death in southern Ontario, with emphasis on myocarditis". Can Med Assoc J. 120 (6): 676–80, 706. PMC 1819176. PMID 436050.
  3. 3.0 3.1 Hosenpud JD, McAnulty JH, Niles NR (1986). "Unexpected myocardial disease in patients with life threatening arrhythmias". Br Heart J. 56 (1): 55–61. PMC 1277385. PMID 3730208.
  4. Scartazzini R, Schneider P, Bickel H (1975). "[New beta-lactam antibiotics. Functionalisation of the cephem 3-position with sulfur or nitrogen bearing substituents (author's transl)]". Helv Chim Acta. 58 (8): 2437–50. doi:10.1002/hlca.19750580824. PMID 1194054.
  5. McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM; et al. (2000). "Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis". N Engl J Med. 342 (10): 690–5. doi:10.1056/NEJM200003093421003. PMID 10706898.

Template:WH Template:WS